Summary
The global Biomedical Materials Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Biomedical Materials Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Biomedical Materials Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Royal DSM
- BASF
- Corbion
- Covestro (Subsidiary of Bayer AG)
- Invibio Ltd. (Subsidiary of Victrex PLC)
- Carpenter Technology
- Roche
- Evonik Industries
- Berkeley Advanced Biomaterails
- Cam Bioceramics
- Celanese
- Formosa Biomedical Technology
- etc.
By the Product Type, the market is primarily segmented into:
- Metallic Biomaterials
- Ceramics
- Polymers
- Natural Biomaterials
- Other
By Applications, the market is segmented into:
- Cardiovascular
- Orthopedic
- Ophthalmology
- Wound Healing
- Tissue Engineering
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Biomedical Materials Market Report:
- To assess the size of the market by value and volume
- Analyze the Biomedical Materials Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Biomedical Materials Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Biomedical Materials Market
The Biomedical Materials Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Biomedical Materials Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biomedical Materials Industry
1.7 COVID-19 Impact: Biomedical Materials Market Trends
2 Global Biomedical Materials Quarterly Market Size Analysis
2.1 Biomedical Materials Business Impact Assessment - COVID-19
2.1.1 Global Biomedical Materials Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Biomedical Materials Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biomedical Materials Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Biomedical Materials Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Biomedical Materials Factory Price by Manufacturers
3.3 Location of Key Manufacturers Biomedical Materials Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Biomedical Materials Market
3.5 Key Manufacturers Biomedical Materials Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Biomedical Materials Segments, By Type
4.1 Introduction
1.4.1 Metallic Biomaterials
1.4.2 Ceramics
1.4.3 Polymers
1.4.4 Natural Biomaterials
1.4.5 Other
4.2 By Type, Global Biomedical Materials Market Size, 2019-2021
4.2.1 By Type, Global Biomedical Materials Market Size by Type, 2020-2021
4.2.2 By Type, Global Biomedical Materials Price, 2020-2021
5 Impact of Covid-19 on Biomedical Materials Segments, By Application
5.1 Overview
5.5.1 Cardiovascular
5.5.2 Orthopedic
5.5.3 Ophthalmology
5.5.4 Wound Healing
5.5.5 Tissue Engineering
5.5.6 Other
5.2 By Application, Global Biomedical Materials Market Size, 2019-2021
5.2.1 By Application, Global Biomedical Materials Market Size by Application, 2019-2021
5.2.2 By Application, Global Biomedical Materials Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Royal DSM
7.1.1 Royal DSM Business Overview
7.1.2 Royal DSM Biomedical Materials Quarterly Production and Revenue, 2020
7.1.3 Royal DSM Biomedical Materials Product Introduction
7.1.4 Royal DSM Response to COVID-19 and Related Developments
7.2 BASF
7.2.1 BASF Business Overview
7.2.2 BASF Biomedical Materials Quarterly Production and Revenue, 2020
7.2.3 BASF Biomedical Materials Product Introduction
7.2.4 BASF Response to COVID-19 and Related Developments
7.3 Corbion
7.3.1 Corbion Business Overview
7.3.2 Corbion Biomedical Materials Quarterly Production and Revenue, 2020
7.3.3 Corbion Biomedical Materials Product Introduction
7.3.4 Corbion Response to COVID-19 and Related Developments
7.4 Covestro (Subsidiary of Bayer AG)
7.4.1 Covestro (Subsidiary of Bayer AG) Business Overview
7.4.2 Covestro (Subsidiary of Bayer AG) Biomedical Materials Quarterly Production and Revenue, 2020
7.4.3 Covestro (Subsidiary of Bayer AG) Biomedical Materials Product Introduction
7.4.4 Covestro (Subsidiary of Bayer AG) Response to COVID-19 and Related Developments
7.5 Invibio Ltd. (Subsidiary of Victrex PLC)
7.5.1 Invibio Ltd. (Subsidiary of Victrex PLC) Business Overview
7.5.2 Invibio Ltd. (Subsidiary of Victrex PLC) Biomedical Materials Quarterly Production and Revenue, 2020
7.5.3 Invibio Ltd. (Subsidiary of Victrex PLC) Biomedical Materials Product Introduction
7.5.4 Invibio Ltd. (Subsidiary of Victrex PLC) Response to COVID-19 and Related Developments
7.6 Carpenter Technology
7.6.1 Carpenter Technology Business Overview
7.6.2 Carpenter Technology Biomedical Materials Quarterly Production and Revenue, 2020
7.6.3 Carpenter Technology Biomedical Materials Product Introduction
7.6.4 Carpenter Technology Response to COVID-19 and Related Developments
7.7 Roche
7.7.1 Roche Business Overview
7.7.2 Roche Biomedical Materials Quarterly Production and Revenue, 2020
7.7.3 Roche Biomedical Materials Product Introduction
7.7.4 Roche Response to COVID-19 and Related Developments
7.8 Evonik Industries
7.8.1 Evonik Industries Business Overview
7.8.2 Evonik Industries Biomedical Materials Quarterly Production and Revenue, 2020
7.8.3 Evonik Industries Biomedical Materials Product Introduction
7.8.4 Evonik Industries Response to COVID-19 and Related Developments
7.9 Berkeley Advanced Biomaterails
7.9.1 Berkeley Advanced Biomaterails Business Overview
7.9.2 Berkeley Advanced Biomaterails Biomedical Materials Quarterly Production and Revenue, 2020
7.9.3 Berkeley Advanced Biomaterails Biomedical Materials Product Introduction
7.9.4 Berkeley Advanced Biomaterails Response to COVID-19 and Related Developments
7.10 Cam Bioceramics
7.10.1 Cam Bioceramics Business Overview
7.10.2 Cam Bioceramics Biomedical Materials Quarterly Production and Revenue, 2020
7.10.3 Cam Bioceramics Biomedical Materials Product Introduction
7.10.4 Cam Bioceramics Response to COVID-19 and Related Developments
7.11 Celanese
7.11.1 Celanese Business Overview
7.11.2 Celanese Biomedical Materials Quarterly Production and Revenue, 2020
7.11.3 Celanese Biomedical Materials Product Introduction
7.11.4 Celanese Response to COVID-19 and Related Developments
7.12 Formosa Biomedical Technology
7.12.1 Formosa Biomedical Technology Business Overview
7.12.2 Formosa Biomedical Technology Biomedical Materials Quarterly Production and Revenue, 2020
7.12.3 Formosa Biomedical Technology Biomedical Materials Product Introduction
7.12.4 Formosa Biomedical Technology Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Biomedical Materials Supply Chain Analysis
8.1.1 Biomedical Materials Supply Chain Analysis
8.1.2 Covid-19 Impact on Biomedical Materials Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Biomedical Materials Distribution Channels
8.2.2 Covid-19 Impact on Biomedical Materials Distribution Channels
8.2.3 Biomedical Materials Distributors
8.3 Biomedical Materials Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of Table
List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biomedical Materials Assessment
Table 9. COVID-19 Impact: Biomedical Materials Market Trends
Table 10. COVID-19 Impact Global Biomedical Materials Market Size
Table 11. Global Biomedical Materials Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Biomedical Materials Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Biomedical Materials Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Biomedical Materials Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Biomedical Materials Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Biomedical Materials Market Growth Drivers
Table 17. Global Biomedical Materials Market Restraints
Table 18. Global Biomedical Materials Market Opportunities
Table 19. Global Biomedical Materials Market Challenges
Table 20. Key Manufacturers Biomedical Materials Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Biomedical Materials Market Size, 2019 (K MT) & (US$ Million)
Table 22. Biomedical Materials Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Biomedical Materials Manufacturing Plants
Table 24. Key Manufacturers Biomedical Materials Market Served
Table 25. Date of Key Manufacturers Enter into Biomedical Materials Market
Table 26. Key Manufacturers Biomedical Materials Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biomedical Materials Market Size by Type, 2020, (US$ Million)
Table 29. Global Biomedical Materials Market Size by Type, 2020 (K MT)
Table 30. Global Biomedical Materials Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Biomedical Materials Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Biomedical Materials Market Size by Application, 2020-2021 (K MT)
Table 33. Global Biomedical Materials Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Biomedical Materials Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Biomedical Materials Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Biomedical Materials Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Biomedical Materials Market Size, 2019-2021 (K MT)
Table 38. US Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Biomedical Materials Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Biomedical Materials Market Size, 2019-2021 (K MT)
Table 43. Germany Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Biomedical Materials Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Biomedical Materials Market Size, 2019-2021 (K MT)
Table 50. China Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Biomedical Materials Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Royal DSM Business Overview
Table 58. Royal DSM Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Royal DSM Biomedical Materials Product
Table 60. Royal DSM Response to COVID-19 and Related Developments
Table 61. BASF Business Overview
Table 62. BASF Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. BASF Biomedical Materials Product
Table 64. BASF Response to COVID-19 and Related Developments
Table 65. Corbion Business Overview
Table 66. Corbion Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Corbion Biomedical Materials Product
Table 68. Corbion Response to COVID-19 and Related Developments
Table 69. Covestro (Subsidiary of Bayer AG) Business Overview
Table 70. Covestro (Subsidiary of Bayer AG) Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Covestro (Subsidiary of Bayer AG) Biomedical Materials Product
Table 72. Covestro (Subsidiary of Bayer AG) Response to COVID-19 and Related Developments
Table 73. Invibio Ltd. (Subsidiary of Victrex PLC) Business Overview
Table 74. Invibio Ltd. (Subsidiary of Victrex PLC) Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Invibio Ltd. (Subsidiary of Victrex PLC) Biomedical Materials Product
Table 76. Invibio Ltd. (Subsidiary of Victrex PLC) Response to COVID-19 and Related Developments
Table 77. Carpenter Technology Business Overview
Table 78. Carpenter Technology Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Carpenter Technology Biomedical Materials Product
Table 80. Carpenter Technology Response to COVID-19 and Related Developments
Table 81. Roche Business Overview
Table 82. Roche Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Roche Biomedical Materials Product
Table 84. Roche Response to COVID-19 and Related Developments
Table 85. Evonik Industries Business Overview
Table 86. Evonik Industries Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Evonik Industries Biomedical Materials Product
Table 88. Evonik Industries Response to COVID-19 and Related Developments
Table 89. Berkeley Advanced Biomaterails Business Overview
Table 90. Berkeley Advanced Biomaterails Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Berkeley Advanced Biomaterails Biomedical Materials Product
Table 92. Berkeley Advanced Biomaterails Response to COVID-19 and Related Developments
Table 93. Cam Bioceramics Business Overview
Table 94. Cam Bioceramics Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Cam Bioceramics Biomedical Materials Product
Table 96. Cam Bioceramics Response to COVID-19 and Related Developments
Table 97. Celanese Business Overview
Table 98. Celanese Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Celanese Biomedical Materials Product
Table 100. Celanese Response to COVID-19 and Related Developments
Table 101. Formosa Biomedical Technology Business Overview
Table 102. Formosa Biomedical Technology Biomedical Materials Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Formosa Biomedical Technology Biomedical Materials Product
Table 104. Formosa Biomedical Technology Response to COVID-19 and Related Developments
Table 105. Biomedical Materials Distributors List
Table 106. Biomedical Materials Customers List
Table 107. Covid-19 Impact on Biomedical Materials Customers
List of Figures
Figure 1. Biomedical Materials Product Picture
Figure 2. Biomedical Materials Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biomedical Materials Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biomedical Materials Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biomedical Materials Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biomedical Materials Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biomedical Materials Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biomedical Materials Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biomedical Materials Market Size Market Share, 2019-2021
Request Discount 
Inquire Before Buy
